NasdaqGM - Nasdaq Real Time Price • USD
Longboard Pharmaceuticals, Inc. (LBPH)
At close: April 25 at 4:00 PM EDT
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
50,697.00
70,616.00
108,952.00
56,238.00
Total Liabilities Net Minority Interest
9,774.00
9,146.00
5,629.00
58,930.00
Total Equity Gross Minority Interest
40,923.00
61,470.00
103,323.00
-2,692.00
Total Capitalization
40,923.00
61,470.00
103,323.00
-2,692.00
Preferred Stock Equity
--
--
--
55,795.00
Common Stock Equity
40,923.00
61,470.00
103,323.00
-2,692.00
Capital Lease Obligations
475.00
740.00
524.00
--
Net Tangible Assets
40,923.00
61,470.00
103,323.00
-2,692.00
Working Capital
40,447.00
61,074.00
102,940.00
52,227.00
Invested Capital
40,923.00
61,470.00
103,323.00
-2,692.00
Tangible Book Value
40,923.00
61,470.00
103,323.00
-2,692.00
Total Debt
475.00
740.00
524.00
--
Share Issued
24,517.25
17,215.35
17,070.16
16,916.99
Ordinary Shares Number
24,517.25
17,215.35
17,070.16
16,916.99
12/31/2020 - 3/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EWTX Edgewise Therapeutics, Inc.
15.94
-1.06%
MLYS Mineralys Therapeutics, Inc.
11.04
-2.82%
SYRE Spyre Therapeutics, Inc.
32.47
-1.58%
FULC Fulcrum Therapeutics, Inc.
7.13
-2.06%
LRMR Larimar Therapeutics, Inc.
6.33
-2.01%
KYMR Kymera Therapeutics, Inc.
33.35
-5.28%
CGEM Cullinan Therapeutics, Inc.
19.25
+1.91%
PRQR ProQR Therapeutics N.V.
1.9600
-2.49%
LXEO Lexeo Therapeutics, Inc.
12.16
-2.72%
APGE Apogee Therapeutics, Inc.
45.86
-1.46%